Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome

Several studies have shown that patients with schizophrenia are at high risk for metabolic syndrome (MetS) and bioenergetic dysfunction. Because acylcarnitines are involved in bioenergetic pathways and reflect the functioning of mitochondria, we hypothesized that these compounds are biomarkers of Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Mednova, Irina A., Chernonosov, Alexander A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Koval, Vladimir V., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504797/
https://www.ncbi.nlm.nih.gov/pubmed/36144254
http://dx.doi.org/10.3390/metabo12090850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504797/
https://www.ncbi.nlm.nih.gov/pubmed/36144254
http://dx.doi.org/10.3390/metabo12090850

Ejemplares similares